Anthem Bioscienc
₹870
- Market Cap
- ₹46,480Cr.
- P/E Ratio
- 78.3
- P/B Ratio
- 16.05
- EPS (TTM)
- ₹11.11
- Div Yield
- 0.23%
- ROCE
- 30.4%
- ROE
- 22.3%
52W Low: ₹57952W High: ₹978
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 26.0% a year over three years.
- Debt is 0.02× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Anthem_Bioscienc — Price
Interval
Style
Failed: 503
Scorecard
Market: risk-off · breadth 376/8Minerviniuptrend checks met
69RS Rankvs all stocks, 1–99
bullRSI Regimemomentum range
23Trend (ADX)trend strength
0/4CAN SLIMprice & volume checks
downSupertrendprice vs trailing line
accum.Volume Flowbuying vs selling volume
Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 78.3P/E: 78.3 | P/B: 16.05Growth
GrowingSales CAGR — 3Y: 26% · 1Y: -2%Profitability
High MarginROCE: 30.4% | ROE: 22.3%Key Metrics
Valuation
PEG Ratio 3.73
Price / Sales 23.22x
Price / FCF 73.0x
Book Value ₹54.2
Margins & returns
Operating Margin 40%
Net Margin 28.8%
Return on Assets 16.8%